FDA inspection

Abbott GmbH: FDA inspection ending May 23, 2025

FDA inspection 1275591 · No Action Indicated (NAI) · Wiesbaden

Key facts

Inspection ID 1275591
Firm Abbott GmbH
FEI number 3002809144
Address Max-Planck Ring 2
City Wiesbaden
Country Germany
Fiscal year 2025
Inspection end date May 23, 2025
Classification No Action Indicated (NAI)
Project area Blood and Blood Products
Product type Biologics

At a glance

  • None Citations
  • None Posted citations
  • No Warning letter followed
  • No Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections